These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10698695)

  • 21. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural origins of efficient proton abstraction from carbon by a catalytic antibody.
    Debler EW; Ito S; Seebeck FP; Heine A; Hilvert D; Wilson IA
    Proc Natl Acad Sci U S A; 2005 Apr; 102(14):4984-9. PubMed ID: 15788533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro abzyme evolution to optimize antibody recognition for catalysis.
    Takahashi N; Kakinuma H; Liu L; Nishi Y; Fujii I
    Nat Biotechnol; 2001 Jun; 19(6):563-7. PubMed ID: 11385462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the importance of second sphere residues in an esterolytic antibody by phage display.
    Arkin MR; Wells JA
    J Mol Biol; 1998 Dec; 284(4):1083-94. PubMed ID: 9837728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ability of single-site mutants of citrate synthase to catalyze proton transfer from the methyl group of dethiaacetyl-coenzyme A, a non-thioester substrate analog.
    Kurz LC; Roble JH; Nakra T; Drysdale GR; Buzan JM; Schwartz B; Drueckhammer DG
    Biochemistry; 1997 Apr; 36(13):3981-90. PubMed ID: 9092828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-catalyzed removal of the p-nitrobenzyl ester protecting group: the molecular basis of broad substrate specificity.
    Kurihara S; Tsumuraya T; Suzuki K; Kuroda M; Liu L; Takaoka Y; Fujii I
    Chemistry; 2000 May; 6(9):1656-62. PubMed ID: 10839182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interplay between binding energy and catalysis in the evolution of a catalytic antibody.
    Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG
    Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant.
    Mitsuda Y; Hifumi E; Tsuruhata K; Fujinami H; Yamamoto N; Uda T
    Biotechnol Bioeng; 2004 Apr; 86(2):217-25. PubMed ID: 15052642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward bifunctional antibody catalysis.
    Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
    Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of improvement of hydrolytic antibody 6D9 by site-directed mutagenesis.
    Takahashi-Ando N; Shimazaki K; Kakinuma H; Fujii I; Nishi Y
    J Biochem; 2006 Oct; 140(4):509-15. PubMed ID: 16921165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational and inhibitory analysis of a catalytic antibody. Implication for drug discovery.
    Phichith D; Bun S; Padiolleau-Lefèvre S; Banh S; Thomas D; Friboulet A; Avalle B
    Mol Immunol; 2009 Dec; 47(2-3):348-56. PubMed ID: 19828199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalytic digestion of human tumor necrosis factor-α by antibody heavy chain.
    Hifumi E; Higashi K; Uda T
    FEBS J; 2010 Sep; 277(18):3823-32. PubMed ID: 20718866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.
    Boucher G; Said B; Ostler EL; Resmini M; Brocklehurst K; Gallacher G
    Biochem J; 2007 Feb; 401(3):721-6. PubMed ID: 17020536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of essential residues of human alpha-L-fucosidase and tests of its mechanism.
    Liu SW; Chen CS; Chang SS; Mong KK; Lin CH; Chang CW; Tang CY; Li YK
    Biochemistry; 2009 Jan; 48(1):110-20. PubMed ID: 19072333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-directed mutagenesis of proteolytic antibody light chain.
    Gao QS; Sun M; Rees AR; Paul S
    J Mol Biol; 1995 Nov; 253(5):658-64. PubMed ID: 7473741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis.
    Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K
    Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic features of monoclonal antibody i41SL1-2 subunits.
    Hifumi E; Kondo H; Mitsuda Y; Uda T
    Biotechnol Bioeng; 2003 Nov; 84(4):485-93. PubMed ID: 14574707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
    Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
    Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-catalyzed benzoin oxidation as a mechanistic probe for nucleophilic catalysis by an active site lysine.
    Sklute G; Oizerowich R; Shulman H; Keinan E
    Chemistry; 2004 May; 10(9):2159-65. PubMed ID: 15112204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.